Association of Dipping Pattern or Early Morning Surge of BP With Asymptomatic Episodes of Paroxysmal Atrial Fibrillation in Subjects With Hypertension (DIMOSPAF)
NCT ID: NCT02563379
Last Updated: 2015-10-01
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
UNKNOWN
Total Enrollment
200 participants
Study Classification
OBSERVATIONAL
Study Start Date
2015-09-30
Study Completion Date
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The goals of our study are to determine a).the association between abnormal circadian BP and the development of paroxysmal AF in hypertensive patients, b).at which level of TOD, paroxysmal AF episodes are detected in hypertensive subjects, c).if there is any association between systolic and/or diastolic BP levels with AF occurrence, d).whether the mean heart rate during a 24-hr interval is associated with the development of paroxysmal AF, and finally e).examine the relationship between a wide PP and asymptomatic AF episodes in patients with HTN.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nocturnal Blood Pressure Dipping and Ventricular Repolarization in Hypertension
NCT07200856
Hypertension
Blood Pressure Monitoring, Ambulatory
Circadian Rhythm
+2 more
NOT_YET_RECRUITING
Dapagliflozin on Blood Pressure Variability and Ambulatory Arterial Stiffness Index in Hypertension
NCT03592667
Hypertension
UNKNOWN
PHASE4
Monitoring of the Influence of Approved PH-therapies RV-PA Coupling
NCT05935865
Pulmonary Hypertension
RECRUITING
Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy
NCT00295542
Hypertension
COMPLETED
PHASE4
Prevalence of Primary Aldosteronism Among Hypertensive Patients With Atrial Arythmia
NCT04115280
Primary Aldosteronism
Atrial Fibrillation
COMPLETED
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Atrial fibrillation, also known as AF or Afib, is an abnormal and irregular heart rhythm in which electrical signals are generated chaotically throughout the upper chambers (atria) of the heart. According to the NICE clinical guidelines, a patient who experiences recurrent (two or more) AF episodes that terminate spontaneously without any treatment in less than seven days, and usually within 48 hours is classified as having paroxysmal AF. It has been shown that paroxysmal AF comprises approximately between 25% and 62% of cases of AF, and it is estimated that both its incidence and prevalence are likely to rise as the worldwide population ages dramatically over the next twenty years. Interestingly, hospitalizations due to AF have increased sharply in the US during the last decade, posing thereby a heavy economic burden on the health care system and society.
Likewise, hypertension (HTN) also constitutes a major public health problem globally, and its prevalence is set to increase owing to widespread population ageing. This epidemiological trend is especially prevalent in rapidly developing countries where early routine screening at any point of health care is underutilized among risk subjects, due to several perceived barriers. Moreover, HTN awareness is critical for optimal BP control since under-diagnosis, under-treatment and/or un-treatment of high BP levels can have deleterious effects on the cardiovascular system. In addition, HTN is the single most important risk factor for cerebrovascular stroke, and it has been clearly demonstrated that it is also associated with structural and functional changes in the myocardium that favor the development of AF, further increasing the risk of thromboembolism. Among those alterations, left ventricular hypertrophy (LVH), impaired ventricular filling, left atrial enlargement and slowing of atrial conduction velocity have been identified as important heralds of cardiovascular morbidity and mortality. More specifically, since HTN and AF are two conditions that often co-exist, especially in patients with advanced age, the risk for considerable morbidity and mortality is increased even more, which points towards the significance that optimal BP control holds in the prevention of cardiovascular events. To our knowledge, in the Framingham Heart Study, after controlling for age and other predisposing conditions, HTN and diabetes emerged as the only cardiovascular risk factors predicting AF.
It has also been suggested that nocturnal HTN and non-dipping of BP during sleep are distinct entities that often occur together and are regarded as important harbingers of poor cardiovascular prognosis. Recently, Pierdomenico et al., showed that non-dipper sustained hypertensives have a two-fold greater risk of developing AF than dipper ones. This may be due to the fact that nighttime HTN may be a powerful determinant of long-standing left ventricular diastolic dysfunction, which subsequently increases atrial stretch. Furthermore, it has been observed that nighttime hemodynamics, are associated with higher sympathetic and reduced vagal activity, which may trigger AF. Additionally, sympathetic activation is associated with the stimulation of the renin-angiotensin-aldosterone axis (RAAA), which leads to increased left ventricular diastolic preload, both atrial and ventricular fibrosis, exerting thus direct cellular electrophysiological effects. Besides, scientists suggested that nighttime HTN is better associated with cardiovascular target organ damage (TOD) as compared with the non-dipping pattern.
According to the most recent guidelines of the ESH, the presence of microalbuminuria, increased pulse wave velocity, LVH on echocardiogram and carotid plaques detected during carotid ultrasonography, constitute markers of asymptomatic organ damage and it has been clearly demonstrated from multiple studies that they can predict CV mortality independently of SCORE stratification.
In our study we will try to investigate whether abnormalities in the circadian rhythm of BP (such as extreme dipping or non-dipping pattern, and/or morning surge) in hypertensive subjects with or without TOD are associated with the development of new-onset paroxysmal AF.
24-hr ambulatory BP monitoring (ABPM) along with the 24-hour blood pressure monitors with AF detector will help us to examine the incidence of AF in extremely dippers or non-dippers, and/or patients exhibiting a morning surge in BP, with or without TOD. Some of the questions that we aim to answer while conducting this study are whether an asymptomatic AF episode is more commonly detected in extreme dippers, non-dippers, or morning surgers, during daytime or during nighttime, or whether TOD is associated with asymptomatic AF episodes.
Importantly, Iqbal et al, demonstrated that there is an association between AF and nighttime DBP. On top of that, during the past decade, a research study conducted in 546 hypertensive subjects aged \< 60 years of age and who were followed-up for 9.2 years, showed that DBP, whether 24-hr mean, daytime mean, or nighttime mean, provided the most incremental value for the prediction of morbid events. Thereby, we want to examine if AF episodes have any association with the 24hr systolic and the diastolic blood pressure (DBP) levels. It would also be interesting to observe for any associations between AF occurrence and the mean 24-hr ABPM and office heart rate (HR).
Moreover, it has been showed that pulse pressure (PP) determines left atrial enlargement in non-dipper patients with never-treated essential HTN. Thus, in our study, we will also examine whether a wide PP is associated with silent AF episodes in treated hypertensive subjects.
Summarizing, the goals of our study are to determine a).the association between abnormal circadian BP and the development of paroxysmal AF in hypertensive patients, b).at which level of TOD, paroxysmal AF episodes are detected in hypertensive subjects, c).if there is any association between systolic and/or diastolic BP levels with AF occurrence, d).whether the mean heart rate during a 24-hr interval is associated with the development of paroxysmal AF, and finally e).examine the relationship between a wide PP and asymptomatic AF episodes in patients with HTN.
Study Population We will evaluate all adult patients referred by their family physicians to the "Hypertension and Cardiovascular Prevention" Outpatient Clinic at Evangelismos General Hospital in Athens, from June 2015 to present.
All patients with an average office systolic BP ≥140 mmHg and/or an average diastolic BP ≥90 mmHg on three consecutive visits are considered as having essential HTN. Furthermore, individuals under treatment with one or more antihypertensive drug are also enrolled in the study.
Objectives Primary endpoint
• To investigate whether nighttime BP patterns (extreme dipping, normal dipping or reduced dipping and non-dipping including risers) or early morning surge are associated with the detection of paroxysmal AF in hypertensive subjects.
Further definitions Normal diurnal systolic and diastolic BP pattern: arterial BP has a daily variation characterized by substantial reductions during sleep, a rapid rise upon awakening, and increased variability during the awake period in ambulant normal subjects and hypertensive patients.
Reduced diurnal systolic and diastolic BP pattern: nocturnal systolic and/or DBP fall from 1 to 10% of daytime values or night/day systolic and/or diastolic BP ratio \<1 and \>0.9.
Nocturnal HTN: increased absolute level of night time systolic and/or diastolic BP (≥120/70 mmHg).19 Dipping pattern is defined as daytime-nighttime BP/daytime BP reduction - based on either ABP or home BP (HBP) monitoring- greater than 10% for systolic and/or diastolic BP. Nighttime HTN is defined as nighttime ABP or HBP ≥125/75 mmHg (systolic and/or diastolic).
Non-dipping and rising: no reduction or increase in nocturnal systolic and/or diastolic BP or night/day systolic and/or diastolic BP ratio ≥1.
Extreme dipping: marked nocturnal systolic and/or diastolic BP fall\>20% of daytime systolic and/or diastolic values or night/day systolic and/or diastolic BP ratio \<0.8.
Morning surge: excessive systolic and/or diastolic BP elevation rising in the morning.
Secondary endpoints
* To detect asymptomatic and intermittent AF using a 24h ABPM with atrial fibrillation detector device and to compare its accuracy with Holter monitoring.
* To investigate the agreement in the detection of paroxysmal AF using simultaneously the 24h-ABP with AF detection device and loop recording.
* To observe at which level of TOD, asymptomatic AF episodes are more commonly detected.
* To study if there is any relationship between systolic and/or diastolic BP levels with AF occurrence.
* To examine whether office HR or mean HR using ABPM is associated with the development of silent AF episodes.
* To examine whether a wide PP in ABPM is associated with the development of silent AF episodes.
Variables used to determine the primary and secondary endpoints
* Sociodemographic data (birth date, gender, education level, employment status, place of residence, smoking status/habits, alcohol consumption)
* Anthropometric characteristics (body weight, height, waist circumference)
* Any abnormal findings on physical examination
* Clinical relevant medical history and comorbidities
* Concomitant medications
* Electrocardiographic assessment
* Investigation of TOD, including echocardiography, carotid artery triplex, 24h-urine albumin excretion and ABI
* Recent laboratory testing results including hemoglobin, hematocrit, blood glucose, kidney and liver function tests
* Management of HTN (pharmacologic and non-pharmacologic treatment)
Inclusion Criteria
* Patients diagnosed with essential HTN (office BP\>140/90mmHg) or patients receiving at least one antihypertensive medication (ie. RAAA inhibitors or diuretic), aged 18-85 years of age.
* Patients with at least one of the following risk factors, organ damage or other evidence of cardiovascular disease:
* Previous stroke
* Transient ischemic attack (TIA)
* Systemic embolism
* Diabetes mellitus type 2
* Obesity
* Obstructive sleep apnea (OSA)
* Dyslipidemia
* History of coronary artery disease (CAD)
* Valvular heart disease (VHD)
* Echocardiographic findings attributed to HTN (ie. diastolic dysfunction, LVH)
* White coat hypertension (WCH), masked hypertension (MH)
* Positive family history for rhythm disturbances
Exclusion Criteria
* Patients already diagnosed with paroxysmal or permanent AF
* Severe renal insufficiency (eGFR according to MDRD formula \<25ml/min/1.73m2)
* Patients unable to attend follow-up visits
* Clinical evidence of severe heart failure
* Suspected secondary HTN
* Mental disorders
* Patients with cancer
The study protocol needs to be approved by the scientific board of the hospital and signed informed consent needs to be obtained from all participants.
Study Design We are going to conduct a cross-sectional, observational study.
Likewise, hypertension (HTN) also constitutes a major public health problem globally, and its prevalence is set to increase owing to widespread population ageing. This epidemiological trend is especially prevalent in rapidly developing countries where early routine screening at any point of health care is underutilized among risk subjects, due to several perceived barriers. Moreover, HTN awareness is critical for optimal BP control since under-diagnosis, under-treatment and/or un-treatment of high BP levels can have deleterious effects on the cardiovascular system. In addition, HTN is the single most important risk factor for cerebrovascular stroke, and it has been clearly demonstrated that it is also associated with structural and functional changes in the myocardium that favor the development of AF, further increasing the risk of thromboembolism. Among those alterations, left ventricular hypertrophy (LVH), impaired ventricular filling, left atrial enlargement and slowing of atrial conduction velocity have been identified as important heralds of cardiovascular morbidity and mortality. More specifically, since HTN and AF are two conditions that often co-exist, especially in patients with advanced age, the risk for considerable morbidity and mortality is increased even more, which points towards the significance that optimal BP control holds in the prevention of cardiovascular events. To our knowledge, in the Framingham Heart Study, after controlling for age and other predisposing conditions, HTN and diabetes emerged as the only cardiovascular risk factors predicting AF.
It has also been suggested that nocturnal HTN and non-dipping of BP during sleep are distinct entities that often occur together and are regarded as important harbingers of poor cardiovascular prognosis. Recently, Pierdomenico et al., showed that non-dipper sustained hypertensives have a two-fold greater risk of developing AF than dipper ones. This may be due to the fact that nighttime HTN may be a powerful determinant of long-standing left ventricular diastolic dysfunction, which subsequently increases atrial stretch. Furthermore, it has been observed that nighttime hemodynamics, are associated with higher sympathetic and reduced vagal activity, which may trigger AF. Additionally, sympathetic activation is associated with the stimulation of the renin-angiotensin-aldosterone axis (RAAA), which leads to increased left ventricular diastolic preload, both atrial and ventricular fibrosis, exerting thus direct cellular electrophysiological effects. Besides, scientists suggested that nighttime HTN is better associated with cardiovascular target organ damage (TOD) as compared with the non-dipping pattern.
According to the most recent guidelines of the ESH, the presence of microalbuminuria, increased pulse wave velocity, LVH on echocardiogram and carotid plaques detected during carotid ultrasonography, constitute markers of asymptomatic organ damage and it has been clearly demonstrated from multiple studies that they can predict CV mortality independently of SCORE stratification.
In our study we will try to investigate whether abnormalities in the circadian rhythm of BP (such as extreme dipping or non-dipping pattern, and/or morning surge) in hypertensive subjects with or without TOD are associated with the development of new-onset paroxysmal AF.
24-hr ambulatory BP monitoring (ABPM) along with the 24-hour blood pressure monitors with AF detector will help us to examine the incidence of AF in extremely dippers or non-dippers, and/or patients exhibiting a morning surge in BP, with or without TOD. Some of the questions that we aim to answer while conducting this study are whether an asymptomatic AF episode is more commonly detected in extreme dippers, non-dippers, or morning surgers, during daytime or during nighttime, or whether TOD is associated with asymptomatic AF episodes.
Importantly, Iqbal et al, demonstrated that there is an association between AF and nighttime DBP. On top of that, during the past decade, a research study conducted in 546 hypertensive subjects aged \< 60 years of age and who were followed-up for 9.2 years, showed that DBP, whether 24-hr mean, daytime mean, or nighttime mean, provided the most incremental value for the prediction of morbid events. Thereby, we want to examine if AF episodes have any association with the 24hr systolic and the diastolic blood pressure (DBP) levels. It would also be interesting to observe for any associations between AF occurrence and the mean 24-hr ABPM and office heart rate (HR).
Moreover, it has been showed that pulse pressure (PP) determines left atrial enlargement in non-dipper patients with never-treated essential HTN. Thus, in our study, we will also examine whether a wide PP is associated with silent AF episodes in treated hypertensive subjects.
Summarizing, the goals of our study are to determine a).the association between abnormal circadian BP and the development of paroxysmal AF in hypertensive patients, b).at which level of TOD, paroxysmal AF episodes are detected in hypertensive subjects, c).if there is any association between systolic and/or diastolic BP levels with AF occurrence, d).whether the mean heart rate during a 24-hr interval is associated with the development of paroxysmal AF, and finally e).examine the relationship between a wide PP and asymptomatic AF episodes in patients with HTN.
Study Population We will evaluate all adult patients referred by their family physicians to the "Hypertension and Cardiovascular Prevention" Outpatient Clinic at Evangelismos General Hospital in Athens, from June 2015 to present.
All patients with an average office systolic BP ≥140 mmHg and/or an average diastolic BP ≥90 mmHg on three consecutive visits are considered as having essential HTN. Furthermore, individuals under treatment with one or more antihypertensive drug are also enrolled in the study.
Objectives Primary endpoint
• To investigate whether nighttime BP patterns (extreme dipping, normal dipping or reduced dipping and non-dipping including risers) or early morning surge are associated with the detection of paroxysmal AF in hypertensive subjects.
Further definitions Normal diurnal systolic and diastolic BP pattern: arterial BP has a daily variation characterized by substantial reductions during sleep, a rapid rise upon awakening, and increased variability during the awake period in ambulant normal subjects and hypertensive patients.
Reduced diurnal systolic and diastolic BP pattern: nocturnal systolic and/or DBP fall from 1 to 10% of daytime values or night/day systolic and/or diastolic BP ratio \<1 and \>0.9.
Nocturnal HTN: increased absolute level of night time systolic and/or diastolic BP (≥120/70 mmHg).19 Dipping pattern is defined as daytime-nighttime BP/daytime BP reduction - based on either ABP or home BP (HBP) monitoring- greater than 10% for systolic and/or diastolic BP. Nighttime HTN is defined as nighttime ABP or HBP ≥125/75 mmHg (systolic and/or diastolic).
Non-dipping and rising: no reduction or increase in nocturnal systolic and/or diastolic BP or night/day systolic and/or diastolic BP ratio ≥1.
Extreme dipping: marked nocturnal systolic and/or diastolic BP fall\>20% of daytime systolic and/or diastolic values or night/day systolic and/or diastolic BP ratio \<0.8.
Morning surge: excessive systolic and/or diastolic BP elevation rising in the morning.
Secondary endpoints
* To detect asymptomatic and intermittent AF using a 24h ABPM with atrial fibrillation detector device and to compare its accuracy with Holter monitoring.
* To investigate the agreement in the detection of paroxysmal AF using simultaneously the 24h-ABP with AF detection device and loop recording.
* To observe at which level of TOD, asymptomatic AF episodes are more commonly detected.
* To study if there is any relationship between systolic and/or diastolic BP levels with AF occurrence.
* To examine whether office HR or mean HR using ABPM is associated with the development of silent AF episodes.
* To examine whether a wide PP in ABPM is associated with the development of silent AF episodes.
Variables used to determine the primary and secondary endpoints
* Sociodemographic data (birth date, gender, education level, employment status, place of residence, smoking status/habits, alcohol consumption)
* Anthropometric characteristics (body weight, height, waist circumference)
* Any abnormal findings on physical examination
* Clinical relevant medical history and comorbidities
* Concomitant medications
* Electrocardiographic assessment
* Investigation of TOD, including echocardiography, carotid artery triplex, 24h-urine albumin excretion and ABI
* Recent laboratory testing results including hemoglobin, hematocrit, blood glucose, kidney and liver function tests
* Management of HTN (pharmacologic and non-pharmacologic treatment)
Inclusion Criteria
* Patients diagnosed with essential HTN (office BP\>140/90mmHg) or patients receiving at least one antihypertensive medication (ie. RAAA inhibitors or diuretic), aged 18-85 years of age.
* Patients with at least one of the following risk factors, organ damage or other evidence of cardiovascular disease:
* Previous stroke
* Transient ischemic attack (TIA)
* Systemic embolism
* Diabetes mellitus type 2
* Obesity
* Obstructive sleep apnea (OSA)
* Dyslipidemia
* History of coronary artery disease (CAD)
* Valvular heart disease (VHD)
* Echocardiographic findings attributed to HTN (ie. diastolic dysfunction, LVH)
* White coat hypertension (WCH), masked hypertension (MH)
* Positive family history for rhythm disturbances
Exclusion Criteria
* Patients already diagnosed with paroxysmal or permanent AF
* Severe renal insufficiency (eGFR according to MDRD formula \<25ml/min/1.73m2)
* Patients unable to attend follow-up visits
* Clinical evidence of severe heart failure
* Suspected secondary HTN
* Mental disorders
* Patients with cancer
The study protocol needs to be approved by the scientific board of the hospital and signed informed consent needs to be obtained from all participants.
Study Design We are going to conduct a cross-sectional, observational study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Hypertension - Atrial Fibrillation
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Observational Model Type
COHORT
Study Time Perspective
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dippers
Dipping pattern is defined as daytime-nighttime BP/daytime BP reduction - based on either ABP monitoring- greater than 10% for systolic and/or diastolic BP.
Extreme dipping is marked nocturnal systolic and/or diastolic BP fall\>20% of daytime systolic and/or diastolic values or night/day systolic and/or diastolic BP ratio \<0.8.
Patients in this group will be dippers or extreme dippers. We aim to examine the association of this BP pattern with the development of asymptomatic episodes of paroxysmal atrial fibrillation, in hypertensive subjects.
No interventions assigned to this group
Non-dippers
Non-dipping and rising: no reduction or increase in nocturnal systolic and/or diastolic BP or night/day systolic and/or diastolic BP ratio ≥1.
In this group we aim to examine whether an association exists between the non-dipping pattern and the development of asymptomatic episodes of paroxysmal atrial fibrillation in hypertensive subjects.
No interventions assigned to this group
Morning Hypertensives
It is known that morning surge is the excessive systolic and/or diastolic BP elevation rising in the morning.
Patients in this group will have morning hypertension that is classified into two types:
the "morning-surge" type, characterized by a marked increase in blood pressure in the early morning, and the "nocturnal-hypertension" type, characterized by high blood pressure that persists from nighttime until early morning.
In our study we will examine whether an association between morning hypertension and asymptomatic episodes of paroxysmal atrial fibrillation exists in hypertensive subjects.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients diagnosed with essential HTN (office BP\>140/90mmHg) or patients receiving at least one antihypertensive medication (ie. RAAA inhibitors or diuretic), aged 18-85 years of age.
* Patients with at least one of the following risk factors, organ damage or other evidence of cardiovascular disease:
* Previous stroke
* Transient ischemic attack (TIA)
* Systemic embolism
* Diabetes mellitus type 2
* Obesity
* Obstructive sleep apnea (OSA)
* Dyslipidemia
* History of coronary artery disease (CAD)
* Valvular heart disease (VHD)
* Echocardiographic findings attributed to HTN (ie. diastolic dysfunction, LVH)
* White coat hypertension (WCH), masked hypertension (MH)
* Positive family history for rhythm disturbances
* Patients with at least one of the following risk factors, organ damage or other evidence of cardiovascular disease:
* Previous stroke
* Transient ischemic attack (TIA)
* Systemic embolism
* Diabetes mellitus type 2
* Obesity
* Obstructive sleep apnea (OSA)
* Dyslipidemia
* History of coronary artery disease (CAD)
* Valvular heart disease (VHD)
* Echocardiographic findings attributed to HTN (ie. diastolic dysfunction, LVH)
* White coat hypertension (WCH), masked hypertension (MH)
* Positive family history for rhythm disturbances
Exclusion Criteria
* Patients already diagnosed with paroxysmal or permanent AF
* Severe renal insufficiency (eGFR according to MDRD formula \<25ml/min/1.73m2)
* Patients unable to attend follow-up visits
* Clinical evidence of severe heart failure
* Suspected secondary HTN
* Mental disorders
* Patients with cancer
* Severe renal insufficiency (eGFR according to MDRD formula \<25ml/min/1.73m2)
* Patients unable to attend follow-up visits
* Clinical evidence of severe heart failure
* Suspected secondary HTN
* Mental disorders
* Patients with cancer
Minimum Eligible Age
18 Years
Maximum Eligible Age
85 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Evangelismos Hospital
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emmanuel A. Andreadis
HEAD OF THE FOURTH INTERNAL MEDICINE DEPARTMENT
Responsibility Role
PRINCIPAL_INVESTIGATOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Evangelismos General Hospital
Athens, Attica, Greece
Site Status
Countries
Review the countries where the study has at least one active or historical site.
Greece
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012 Apr;14(4):528-606. doi: 10.1093/europace/eus027. Epub 2012 Mar 1. No abstract available.
Reference Type
RESULT
Lip GY, Hee FL. Paroxysmal atrial fibrillation. QJM. 2001 Dec;94(12):665-78. doi: 10.1093/qjmed/94.12.665.
Reference Type
RESULT
Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013 Oct 15;112(8):1142-7. doi: 10.1016/j.amjcard.2013.05.063. Epub 2013 Jul 4.
Reference Type
RESULT
Patel NJ, Deshmukh A, Pant S, Singh V, Patel N, Arora S, Shah N, Chothani A, Savani GT, Mehta K, Parikh V, Rathod A, Badheka AO, Lafferty J, Kowalski M, Mehta JL, Mitrani RD, Viles-Gonzalez JF, Paydak H. Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning. Circulation. 2014 Jun 10;129(23):2371-9. doi: 10.1161/CIRCULATIONAHA.114.008201. Epub 2014 May 19.
Reference Type
RESULT
Tibazarwa KB, Damasceno AA. Hypertension in developing countries. Can J Cardiol. 2014 May;30(5):527-33. doi: 10.1016/j.cjca.2014.02.020. Epub 2014 Mar 4.
Reference Type
RESULT
Sarafidis PA, Li S, Chen SC, Collins AJ, Brown WW, Klag MJ, Bakris GL. Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med. 2008 Apr;121(4):332-40. doi: 10.1016/j.amjmed.2007.11.025.
Reference Type
RESULT
Rundek T, Sacco RL. Risk factor management to prevent first stroke. Neurol Clin. 2008 Nov;26(4):1007-45, ix. doi: 10.1016/j.ncl.2008.09.001.
Reference Type
RESULT
Healey JS, Connolly SJ. Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target. Am J Cardiol. 2003 May 22;91(10A):9G-14G. doi: 10.1016/s0002-9149(03)00227-3.
Reference Type
RESULT
Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998 Oct 16;82(8A):2N-9N. doi: 10.1016/s0002-9149(98)00583-9.
Reference Type
RESULT
de la Sierra A, Gorostidi M, Banegas JR, Segura J, de la Cruz JJ, Ruilope LM. Nocturnal hypertension or nondipping: which is better associated with the cardiovascular risk profile? Am J Hypertens. 2014 May;27(5):680-7. doi: 10.1093/ajh/hpt175. Epub 2013 Sep 23.
Reference Type
RESULT
Pierdomenico SD, Lapenna D, Cuccurullo F. Risk of atrial fibrillation in dipper and nondipper sustained hypertensive patients. Blood Press Monit. 2008 Aug;13(4):193-7. doi: 10.1097/MBP.0b013e3282feea70.
Reference Type
RESULT
Tsioufis C, Andrikou I, Thomopoulos C, Syrseloudis D, Stergiou G, Stefanadis C. Increased nighttime blood pressure or nondipping profile for prediction of cardiovascular outcomes. J Hum Hypertens. 2011 May;25(5):281-93. doi: 10.1038/jhh.2010.113. Epub 2010 Dec 2.
Reference Type
RESULT
Iqbal P, Stevenson L. Cardiovascular outcomes in patients with normal and abnormal 24-hour ambulatory blood pressure monitoring. Int J Hypertens. 2010 Dec 5;2011:786912. doi: 10.4061/2011/786912.
Reference Type
RESULT
Khattar RS, Swales JD, Dore C, Senior R, Lahiri A. Effect of aging on the prognostic significance of ambulatory systolic, diastolic, and pulse pressure in essential hypertension. Circulation. 2001 Aug 14;104(7):783-9. doi: 10.1161/hc3201.094227.
Reference Type
RESULT
Triantafyllidi H, Ikonomidis I, Lekakis J, Panou F, Georgoula G, Fountoulaki K, Kremastinos D. Pulse pressure determines left atrial enlargement in non-dipper patients with never-treated essential hypertension. J Hum Hypertens. 2007 Nov;21(11):897-9. doi: 10.1038/sj.jhh.1002236. Epub 2007 May 31. No abstract available.
Reference Type
RESULT
Deyneli O, Yazici D, Toprak A, Yuksel M, Aydin H, Tezcan H, Yavuz DG, Akalin S. Diurnal blood pressure abnormalities are related to endothelial dysfunction in patients with non-complicated type 1 diabetes. Hypertens Res. 2008 Nov;31(11):2065-73. doi: 10.1291/hypres.31.2065.
Reference Type
RESULT
Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ; Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005 Jan;45(1):142-61. doi: 10.1161/01.HYP.0000150859.47929.8e. Epub 2004 Dec 20.
Reference Type
RESULT
Millar-Craig MW, Bishop CN, Raftery EB. Circadian variation of blood-pressure. Lancet. 1978 Apr 15;1(8068):795-7. doi: 10.1016/s0140-6736(78)92998-7.
Reference Type
RESULT
Parati G, Stergiou G, O'Brien E, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P, Dolan E, Fagard R, Graves J, Head GA, Imai Y, Kario K, Lurbe E, Mallion JM, Mancia G, Mengden T, Myers M, Ogedegbe G, Ohkubo T, Omboni S, Palatini P, Redon J, Ruilope LM, Shennan A, Staessen JA, vanMontfrans G, Verdecchia P, Waeber B, Wang J, Zanchetti A, Zhang Y; European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014 Jul;32(7):1359-66. doi: 10.1097/HJH.0000000000000221.
Reference Type
RESULT
Verdecchia P, Angeli F, Mazzotta G, Garofoli M, Ramundo E, Gentile G, Ambrosio G, Reboldi G. Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications. Hypertension. 2012 Jul;60(1):34-42. doi: 10.1161/HYPERTENSIONAHA.112.191858. Epub 2012 May 14.
Reference Type
RESULT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MBPS-0915-EA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
HYPERTENSIVE CRISIS AND ATMOSPHERIC PRESSURE RELATIONSHIP
NCT06635603
RECRUITING
Serum miR-455-5p and Cardiac Structure and Function Parameters in Patients With Hypertensive Heart Disease
NCT07033676
ENROLLING_BY_INVITATION
Essential Hypotension and Allostasis Registry
NCT02018497
UNKNOWN
The Transition From Hypertension to Hypertensive Heart Disease and Heart Failure, the PREFERS Hypertension Study
NCT04190420
ENROLLING_BY_INVITATION
Impact of Intravenous Methylprednisolone Treatment on Blood Pressure
NCT03590080
COMPLETED
Effect of Blood Pressure on Myocardial Work in Patients With Hypertension
NCT05062811
UNKNOWN
Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I Hypertension
NCT00971165
COMPLETED
PHASE3
Evaluation of Target Organs Impairment on Patients Suffering From High Blood Pressure
NCT00925470
COMPLETED
Evolution of Pulse Pressure Following Initiation of Antihypertensive Therapy in Patients With Essential Arterial Hypertension
NCT02202525
COMPLETED
Treatment of Supine Hypertension in Autonomic Failure
NCT00223717
COMPLETED
PHASE1
Nocturnal Hypertension and Non-Dipping Blood Pressure
NCT03128177
COMPLETED
NA
Assessment of the Mechanism of Non-cardiac Syncope
NCT05728255
COMPLETED
The Prevalence of Sympathetic Overactivity in Primary Hypertensive Patients.
NCT01295021
COMPLETED
Interactions Between Antihypertensive Drugs and Drugs Prescribed in the Emergency Room
NCT05140590
COMPLETED
Longitudinal Studies of Blood Pressure in the Elderly
NCT00005409
COMPLETED
Mechanisms of Anti-VEGF Induced Hypertension
NCT02156310
COMPLETED
Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events
NCT01173029
COMPLETED
HaemoDYNAMICs in Primary and Secondary Hypertension
NCT01742702
RECRUITING
Acute Effect of Agiotensin-(1-7) in Healthy and Hypertensive Subjects
NCT03001271
UNKNOWN
EARLY_PHASE1
Blood Pressure Reduction in Heart Failure
NCT01255475
COMPLETED
PHASE2/PHASE3
Pharmacogenomic Evaluation of Antihypertensive Responses 2
NCT01203852
COMPLETED
PHASE4
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
NCT05529147
COMPLETED
Use of Impedance Cardiography and Applanation Tonometry for Prediction of the Antihypertensive Effect of Two Drugs
NCT03560804
COMPLETED
NA
Simvastatin and Diastolic Dysfunction
NCT01061450
COMPLETED
PHASE4
National Survey on Hypertension at Hospital
NCT00695266
COMPLETED